Supplementary protection
LT - Benzamido dariniai, skirti ABL1, ABL2 ir BCR-ABL1 aktyvumo inhibavimui
EN - BENZAMIDE DERIVATIVES FOR INHIBITING THE ACTIVITY OF ABL1, ABL2 AND BCR-ABL1
SPC
| (11) |
Number of the document |
C 2861579 |
| (68) |
Number of the document |
2861579
|
| (21) |
Application number for Supplementary Protection Certificate |
PA 2022 523 |
| (22) |
Date of filing the application |
2022-11-10 |
| (41) |
Date of publication of the application |
2022-12-12 |
|
Date of publication of SPC |
2024-08-26 |
| (24) |
Date of coming into effect of SPC |
2033-05-10 |
Applicant
| (71) |
Novartis AG,
Lichtstrasse 35, 4056 Basel,
CH
|
Grantee
| (73) |
Novartis AG,
Lichtstrasse 35, 4056 Basel,
CH
|
Attorney or representative
| (74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
Number, date and code of the country of origin of the first authorization to place the medicinal or plant protection product on the market within regional economic community
| (93) |
EU/1/22/1670, 2022-08-25
|
Calculated date of expiry of the SPC
| (94) |
2037-08-26 |
Name of the product protected by the basic patent
| (95) |
Asciminibas arba farmaciniu požiūriu priimtina jo druska, tokia kaip asciminibo hidrochloridas |
